XTX Topco Ltd Makes New Investment in Maximus, Inc. $MMS

XTX Topco Ltd bought a new stake in shares of Maximus, Inc. (NYSE:MMS) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 9,537 shares of the health services provider’s stock, valued at approximately $669,000.

Several other hedge funds have also recently modified their holdings of the business. Fuller & Thaler Asset Management Inc. increased its holdings in Maximus by 40.0% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 1,729,305 shares of the health services provider’s stock valued at $117,921,000 after buying an additional 494,372 shares during the period. Dimensional Fund Advisors LP boosted its position in Maximus by 20.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,695,582 shares of the health services provider’s stock valued at $115,620,000 after acquiring an additional 288,990 shares in the last quarter. AQR Capital Management LLC boosted its position in Maximus by 177.2% during the 1st quarter. AQR Capital Management LLC now owns 1,173,329 shares of the health services provider’s stock valued at $79,341,000 after acquiring an additional 750,031 shares in the last quarter. Reinhart Partners LLC. increased its holdings in shares of Maximus by 0.3% in the 2nd quarter. Reinhart Partners LLC. now owns 913,856 shares of the health services provider’s stock valued at $64,154,000 after acquiring an additional 2,345 shares during the period. Finally, Boston Partners raised its position in shares of Maximus by 80.5% in the 2nd quarter. Boston Partners now owns 555,500 shares of the health services provider’s stock worth $39,293,000 after acquiring an additional 247,782 shares in the last quarter. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Analysts Set New Price Targets

MMS has been the topic of a number of recent research reports. Zacks Research downgraded Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 27th. Weiss Ratings reissued a “hold (c+)” rating on shares of Maximus in a research report on Wednesday, November 26th. One equities research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, Maximus currently has an average rating of “Hold” and a consensus target price of $90.00.

Insider Activity at Maximus

In other news, insider Michelle F. Link sold 1,610 shares of the company’s stock in a transaction on Wednesday, October 1st. The shares were sold at an average price of $90.86, for a total value of $146,284.60. Following the sale, the insider directly owned 13,508 shares of the company’s stock, valued at $1,227,336.88. This represents a 10.65% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.60% of the stock is owned by company insiders.

Maximus Stock Down 0.6%

Shares of MMS stock opened at $86.51 on Wednesday. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $92.50. The stock’s fifty day moving average price is $85.62 and its 200 day moving average price is $80.21. The company has a debt-to-equity ratio of 0.91, a current ratio of 2.27 and a quick ratio of 2.27. The company has a market cap of $4.71 billion, a price-to-earnings ratio of 15.93 and a beta of 0.56.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, November 20th. The health services provider reported $1.62 EPS for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.01). The business had revenue of $1.32 billion during the quarter, compared to analysts’ expectations of $1.34 billion. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The company’s quarterly revenue was up .2% compared to the same quarter last year. During the same quarter last year, the business posted $1.46 earnings per share. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. On average, research analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, December 1st. Investors of record on Friday, November 14th were issued a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, November 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.4%. Maximus’s payout ratio is 21.58%.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.